Labshake search
Citations for Stemcell Technologies :
301 - 350 of 1527 citations for 3 Hydrazino 5 methyl 4H 1 2 4 triazol 4 ylamine hydrochloride since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2022Quote: ... 3 µM CHIR99021 (STEMCELL Technologies, Vancouver, Canada, 72054), and 1 µM retinoic acid ...
-
bioRxiv - Neuroscience 2023Quote: ... 3 μM CHIR99021 (STEMCELL Technologies; Cat. No. 72054), 2 μM DMH1 (Sigma-Aldrich ...
-
bioRxiv - Immunology 2023Quote: ... Human Peripheral Blood Plasma (3%; Stem Cell Technologies), 3,3‘,5-Triiodo-L-thyronine (1 µM ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... containing 3 μM CHIR99021 (Stem Cell Technologies, Canada), 500 μg.mL-1 bovine serum albumin (BSA ...
-
bioRxiv - Cancer Biology 2024Quote: ... and Interleukin-3 (IL3, StemCell Technologies, Cat#78194) and Interleukin-6 (IL6 ...
-
bioRxiv - Microbiology 2024Quote: ... 5 µM CHIR99021 (StemCell technologies) and 1.25% V/V DMSO) ...
-
bioRxiv - Genetics 2021Quote: ... ∼4 × 105 CS iPSCs containing a c.1569G>A (p.(W523X)) mutation were treated with Accutase (working dilution 1:3 in PBS; StemCell Technologies #07922,). Cells were dissociated to generate a suspension of single cells ...
-
bioRxiv - Neuroscience 2020Quote: The human embryonic stem cell (hESC) line harbouring the GPF reporter at the 3’UTR of CRX locus was expanded in mTeSR™1 (StemCell Technologies) at 37°C and 5% CO2 on 6 well plates pre-coated with Low Growth Factor Matrigel (Corning) ...
-
bioRxiv - Developmental Biology 2020Quote: ... fixed in Methacarn (1/3/6 mixture of acetic acid/chloroform/methanol) overnight at room temperature and stained with carmine alum (Stem Cell Technologies), or fixed in 4% paraformaldehyde overnight at 4°C ...
-
bioRxiv - Cancer Biology 2024Quote: ... Spheroid formation media was made in a 3:1 ratio of cell culture media:MethoCult H4100 (StemCell Technologies, Cat#04100, Cambridge, MA, USA), and the total volume was calculated 100µL per well ...
-
bioRxiv - Cell Biology 2023Quote: ... 1% (v/v) B27™ minus insulin) supplemented with 5 µM CHIR99021 and 33.3 ng Activin A (STEMCELL Technologies). Medium was exchanged daily without CHIR99021 supplementation ...
-
bioRxiv - Bioengineering 2021Quote: ... 50 ng/mL recombinant human FMS-like tyrosine kinase 3 ligand (Flt-3) and 10 ng/mL recombinant human thrombopoietin (TPO; StemCell Technologies). On the following day ...
-
bioRxiv - Neuroscience 2023Quote: ... 50 ng/mL recombinant human FMS-like tyrosine kinase 3 ligand (Flt-3) and 10 ng/mL recombinant human thrombopoietin (TPO; StemCell Technologies). After sublethal conditioning of 9-12 weeks old Gaa−/− mice with 7.5 Gy gamma-irradiation (1.6 Gy/min ...
-
bioRxiv - Immunology 2022Quote: Cells were incubated in 2% FCS in PBS with 1 mM EDTA with human Fc block (STEMCELL Technologies) and stained with Aqua LIVE/DEAD Fixable Dead Cell Stain Kit (Invitrogen ...
-
bioRxiv - Bioengineering 2024Quote: ... Cardiomyocyte Isolation Enzyme 2 (Thermo) was diluted at a 1:1000 ratio into Cardiomyocyte Dissociation Medium (STEMCELL Technologies), and the mixture was pre-warmed to 37°C before use ...
-
bioRxiv - Developmental Biology 2024Quote: ... it was switched to PXGL medium (N2B27 medium supplemented with 1 μM PD0325901, 2 μM XAV939 [STEMCELL Technologies, 72674] ...
-
Arc mediates intercellular synaptic plasticity via IRSp53-dependent extracellular vesicle biogenesisbioRxiv - Neuroscience 2024Quote: ... 2% SM1 (StemCell Technologies), 500 µM L-Glutamine ...
-
bioRxiv - Neuroscience 2023Quote: ... 3 million iPSCs per cell line were plated into 1 well of an AggreWell™800 24-well plate (Stem Cell Technologies, 34811) with 2 mL STEMdiff™ Neural Induction Medium + SMADi + 10 µM Y-27632 ...
-
bioRxiv - Cell Biology 2021Quote: ... Rescue of epithelial integrity was induced by threating hiPSCs for 1 day with LPA (StemCell Technologies, ref. 72694, 5 µM). Chemical disruption of epithelial integrity was induced by threating hiPSCs for 1 day with Blebbistatin (Sigma ...
-
bioRxiv - Genomics 2021Quote: ... Cells were centrifuged (350 x g for 5 minutes) and resuspended in 1 mL of prewarmed dispase (#07913, Stemcell Technologies) and 100 μL of DNase I (#07900 ...
-
bioRxiv - Cancer Biology 2020Quote: ... and the cells then dissociated in 2.5 mg/ml trypsin with 1 mM EDTA and 5 mg/ml dispase (STEMCELL Technologies) with 100 μg/ml DNaseI (Sigma ...
-
bioRxiv - Cancer Biology 2022Quote: ... using base medium (1:1 ratio of DMEM/F12 Glutamax/Neurobasal medium [Gibco], 2% B27 supplement without vitamin A [Gibco], 10% BIT 9500 [StemCell Technologies], and 1 mM glutamine [Gibco]) supplemented with 20ng/ml EGF (Chemicon) ...
-
bioRxiv - Developmental Biology 2022Quote: ... containing 3 μM CHIR99021 (Stem Cell Technologies, Cat.#72054), 500 μg/mL bovine serum albumin (BSA ...
-
bioRxiv - Neuroscience 2021Quote: ... 20ng/ml NT-3 (Stem Cell Technologies Cat # 78074), and Penicillin/Streptomycin (Thermo Fisher ...
-
bioRxiv - Cancer Biology 2021Quote: ... containing 3 mL Methocult GF H4230 (Stem Cell Technologies) and plated in triplicate in 35 mm gridded plates and incubating for 8-10 d.
-
bioRxiv - Immunology 2023Quote: ... and IL-3 (10 ng/mL; Stem Cell Technologies). After 5 days ...
-
bioRxiv - Microbiology 2024Quote: ... containing 3 μM CHIR99021 (Stem Cell Technologies, Cat.#72054), 500 μg/mL bovine serum albumin (BSA ...
-
bioRxiv - Cancer Biology 2024Quote: ... 5% CO2 and 5% O2 in in growth media comprised of StemSpan SFEM II (STEMCELL Technologies) base media supplemented with 20 ng/mL of TPO ...
-
bioRxiv - Cancer Biology 2024Quote: ... 5% CO2 and 5% O2 in AML pre-culture media comprised of MyeloCult H5100 (STEMCELL Technologies) base media supplemented with 20 ng/mL each of TPO ...
-
bioRxiv - Neuroscience 2021Quote: ... 5 µM Dorsomorphin (StemCell Technologies, 72102), 10 µM SB431542 (StemCell Technologies ...
-
bioRxiv - Cell Biology 2021Quote: ... supplemented with 5% FBS (StemCell Technology), L-glutamine (2 mM) ...
-
bioRxiv - Pathology 2022Quote: ... and 5 µM SB431542 (StemCell Technologies). On Days8-14 ...
-
bioRxiv - Cell Biology 2024Quote: ... 5 unit/ml Dispase (Stemcell Technologies) and 0.05 mg/ml DNase I (Roche)) ...
-
bioRxiv - Cell Biology 2024Quote: ... 5 mg/mL dispase (STEMCELL Technologies), supplemented with 100 µg/mL DNase1 (Sigma-Aldrich) ...
-
bioRxiv - Bioengineering 2023Quote: ... 5 µM Y27632 (72034; STEMCELL Technologies), 500 nM SB-202190 (S7067 ...
-
bioRxiv - Pharmacology and Toxicology 2024Quote: ... 5 µM A83-01 (STEMCELL Technologies) and 10 µM forskolin (Sigma-Aldrich) ...
-
bioRxiv - Molecular Biology 2023Quote: ... T cells were cultured at ∼1-2 x 106mL in ImmunoCult-XF T cell expansion medium (StemCell Technologies, Canada) supplemented with Penicillin-Streptomycin (Gibco ...
-
bioRxiv - Neuroscience 2023Quote: ... and cells were passaged 1-2 times per week using an enzyme-free reagent (ReLeSR; Stem Cell Technologies, 05872). Cells were checked for mycoplasma contamination every two weeks ...
-
bioRxiv - Biophysics 2023Quote: ... and the media further supplemented with 30 U mL-1 of human recombinant IL-2 protein (STEMCELL Technologies, USA). T cells were incubated in a humidified incubator with 5% CO2 at 37°C and were split to 0.5×106 cells mL-1 when their concentration surpassed 2.5×106 cells per well or when medium became depleted (turning yellow in color) ...
-
bioRxiv - Cell Biology 2023Quote: Mature organoids are collected by rinsing the maintenance well using 1-2 ml cold DMEM/F12 (Stem Cell Technologies) + 15 mM HEPES + 1x GlutaMax (1:100 35050-038 ...
-
bioRxiv - Developmental Biology 2021Quote: ... Definitive endoderm cells are then differentiated into anterior ventral foregut endoderm (Stage 2) using dual SMAD inhibition for 2 days with 2 µM Dorsomorphin (STEMCELL Technologies, cat#72102) and 10 µM SB431542 (STEMCELL Technologies ...
-
bioRxiv - Biophysics 2023Quote: ... with the addition of Human Recombinant Interleukin 2 (IL-2, STEMCELL Technologies Inc., USA).
-
bioRxiv - Cancer Biology 2021Quote: ... Patient sample mononuclear cells were cultured in RPMI with 10% FBS and 50% HS-5 conditioned media (ATCC) or SFEMII supplemented with 1x StemSpan CD34+ Expansion Media and 1 uM UM729 (StemCell Technologies).
-
bioRxiv - Cancer Biology 2022Quote: ... Patient samples were cultured in RPMI with 10% FBS and 10% HS-5 conditioned media (ATCC) or SFEMII supplemented with 1x StemSpan CD34+ Expansion Media and 1 µM UM729 (StemCell Technologies).
-
bioRxiv - Neuroscience 2021Quote: ... 2 µM XAV939 (STEMCELL Technologies), 10 µM SB431542 hydrate and 2 µg/mL doxycycline hyclate (Sigma) ...
-
bioRxiv - Pathology 2022Quote: ... 2 µM CHIR99021 (StemCell Technologies), and 10 ng/mL Recombinant Human BMP-7(Peprotech) ...
-
bioRxiv - Cell Biology 2022Quote: ... 2% SM1 (Stem Cell Technologies), 15mM HEPES (Gibco) ...
-
bioRxiv - Neuroscience 2024Quote: ... 2% SM1 (05711, STEMCell Technologies), 1% N2 (07152 ...
-
bioRxiv - Neuroscience 2023Quote: ... IWP-2 (STEMCELL Technologies, 72124), RA (Sigma ...
-
bioRxiv - Bioengineering 2023Quote: ... (StemCell Technologies, #129830-38-2) in mTeSR-1 media ...